Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.
This retrospective comparative study aims to evaluate the clinical outcomes, cost-effectiveness, and complication rates associated with two minimally invasive surgical techniques: extended arthroscopic debridement and 18-gauge percutaneous tenotomy. The study included 31 patients with resistant lateral epicondylitis who underwent either arthroscopic debridement (n=14) or percutaneous tenotomy (n=17) between January 2019 and June 2023. Outcomes were assessed using the Mayo Elbow Performance Score (MEPS) and the Patient-Rated Tennis Elbow Evaluation (PRTEE) at preoperative, 3-month, 6-month, and 12-month intervals. Additionally, a detailed cost analysis was performed to compare the economic implications of both surgical techniques. The results demonstrated significant improvements in both groups at 3 and 6 months postoperatively. However, by the 12-month follow-up, the arthroscopic group maintained stable clinical outcomes, while the percutaneous group showed a decline in MEPS and PRTEE scores, suggesting a potential regression in long-term efficacy. Despite this, the percutaneous tenotomy group benefited from a shorter procedure time, fewer complications, and a quicker return to work, making it a highly cost-effective alternative. In conclusion, while extended arthroscopic debridement offers sustained clinical benefits, particularly in long-term follow-up, 18-gauge percutaneous tenotomy emerges as a viable primary intervention due to its simplicity, low complication rate, and significant cost savings. Future studies with larger cohorts and longer follow-up periods are warranted to further elucidate the long-term effectiveness and patient satisfaction associated with these techniques.
Aims: Lateral epicondylitis (LE) is a frequent cause of elbow pain in adults, yet the long-term effectiveness of commonly used interventions remains unclear. Corticosteroid injections offer rapid but short-lived relief, while percutaneous needle tenotomy and extracorporeal shockwave therapy (ESWT) may provide more durable outcomes. This study aimed to compare these three modalities and define patient-acceptable symptom state (PASS) thresholds over 12 months. Methods: A retrospective comparative cohort study was conducted at a single tertiary center including 107 patients with refractory LE who received one of three interventions after ≥3 months of failed conservative treatment: corticosteroid injection (n=43), ESWT (n=36), or percutaneous tenotomy (n=28). Pain and function were evaluated at baseline and 1, 3, 6, and 12 months using the Visual Analog Scale (VAS) and Mayo Elbow Performance Score (MEPS). Global Rating of Change (GROC) was assessed at 12 months to derive ROC-based PASS thresholds. Results: Corticosteroid injection provided the most rapid early improvement at 1 month (VAS 2.9±1.2; MEPS 80.5±7.9), but these benefits declined over time. Tenotomy demonstrated the greatest functional and pain improvement at 12 months (VAS 4.3±1.2; MEPS 79.3±9.3; p
Spinal muscular atrophy (SMA) is a hereditary neuromuscular disorder characterized by progressive lower motor neuron loss, resulting in severe muscle atrophy, fatty degeneration, and impaired tissue perfusion. These changes increase susceptibility to pressure-related soft tissue injuries and delay wound healing.